Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |